[
  {
    "ts": null,
    "headline": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
    "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
    "url": "https://finnhub.io/api/news?id=7fb19a3884e7caa6c6929cccbbce9cc63449259a8753cad5a3ddeaaabe0e0e43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753866480,
      "headline": "Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
      "id": 136129839,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating",
      "url": "https://finnhub.io/api/news?id=7fb19a3884e7caa6c6929cccbbce9cc63449259a8753cad5a3ddeaaabe0e0e43"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: A Bet On Global Healthcare Recovery",
    "summary": "IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs. Read why IXJ ETF is a Buy.",
    "url": "https://finnhub.io/api/news?id=efbb41a862d9a020aa33084c6f7cb09c8955e6659667bd377b0249cad00c608b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753839218,
      "headline": "IXJ: A Bet On Global Healthcare Recovery",
      "id": 136127584,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/174965679/image_174965679.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs. Read why IXJ ETF is a Buy.",
      "url": "https://finnhub.io/api/news?id=efbb41a862d9a020aa33084c6f7cb09c8955e6659667bd377b0249cad00c608b"
    }
  }
]